Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Philip Sharp

Affiliations

  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2019-11-20
  • Director at Vir Biotechnology Inc. (VIR), 2019-10-18
  • Director at Syros Pharmaceuticals Inc. (SYRS), 2019-06-12
  • Director at Biogen Idec Inc. (BIIB), 2009-06-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALNY $20.13 4,967 Director 14,269 2013-01-22 Filing
ALNY $10.75 9,302 Director 9,302 2012-02-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALNY $92.66 810 Director 235,633 2019-11-18 Filing
ALNY $91.97 8,631 Director 236,443 2019-11-18 Filing
ALNY $91.17 5,559 Director 245,074 2019-11-18 Filing
ALNY $91.40 600 Director 235,633 2019-04-15 Filing
ALNY $89.97 400 Director 236,233 2019-04-15 Filing